About the Journal

The Journal of Oncology Pharmacy (JOP) is the official journal of ESOP Global – European Society of Oncology Pharmacy, founded 2000 in Prague. The journal focuses on research, practice development, and professional exchange across oncology pharmacy, supporting the shift from product-focused pharmacy services toward patient-centred clinical oncology practice.

Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors (ICMJE). For further details, authors should consult: International Committee of Medical Journal Editors. "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" New Engl J Med 1997, 336:309–315. Manuscripts that do not comply with these Instructions cannot be considered for publication and will be sent back to the authors.

The Editorial Office is pleased to answer any questions about preparing your manuscript. Contact: terkola@health-concepts.com

Scope

The Journal of Oncology Pharmacy (JOP) is a peer-reviewed pharmaceutical journal in the field of cancer treatment. This scientific journal focuses on all aspects of pharmacy oriented to cancer. It is the official journal of the European Society of Oncology Pharmacy Global.

The journal encompasses all recent issues related to the role of pharmacists in the prevention and treatment of cancers. This includes basic and applied research on the synthesis or extraction, compounding, analysis, stability, pharmacology, side-effects and clinical use of anticancer drugs and adjuvant therapies such as antiemetic, analgesic or complementary medicines. The Journal welcomes articles discussing multi-professional approaches to patient care.

Authors are encouraged to share their research outcomes through original articles, review articles, case reports, short communications, and more. Peer review is managed through an Editorial Manager System; at least two independent reviewers' approval followed by the editor's approval is required for acceptance of any citable manuscript.

Journal Policies

Originality

Each manuscript must be an original contribution that has not been, and will not be, submitted elsewhere while under consideration for JOP. Manuscripts may be subjected to plagiarism-detection software. Material that has appeared in other publications will not be considered unless the prior publication is a meeting abstract not exceeding one printed page. Authors must draw attention to any published work concerning the same patients or subjects in their covering letter.

Authorship

Each listed author must have participated sufficiently in the intellectual content, data analysis, and/or writing of the manuscript to take public responsibility for it. Authorship credit must be based on all four of the following ICMJE criteria:

1. Substantial contributions to conception and design, or acquisition, analysis, or interpretation of data;
2. Drafting the work or revising it critically for important intellectual content;
3. Final approval of the version to be published;
4. Agreement to be accountable for all aspects of the work.

All conditions must be met. Acquisition of funding, data collection, or general supervision alone do not justify authorship. Non-author contributors should be acknowledged in the Acknowledgements section.

AI tool use: Authors who use AI tools in writing, image production, or data analysis must disclose in the Materials and Methods section which tool was used and how. Authors remain fully responsible for all content, including AI-generated portions.

Changes to Authorship

The author list should be finalised before submission. Any addition, deletion or rearrangement of authors after submission requires written approval from the Editor, including (a) the reason for the change and (b) written confirmation from all authors. After acceptance, changes will only be considered in exceptional circumstances and will suspend publication pending review.

Abbreviations, Nomenclature and Symbols

Abbreviations should conform to the AMA Manual of Style. Use Standard International (SI) units. Abbreviations should be used sparingly and spelled out on first use.

Ethics

All articles with original human or animal data must include a statement on ethics approval at the beginning of the Methods section, including: the name and address of the ethics committee; the protocol number; and the date of approval. For example:

"Ethical approval for this study (Ethical Committee N° NAC 207) was provided by the Ethical Committee NAC of Geneva University Hospitals, Geneva, Switzerland on 12 February 2015."

Studies on human participants must state that written informed consent was obtained. Animal studies must state care and licensing guidelines used and report in accordance with the ARRIVE statement. If ethics clearance was not required, please state why.

Informed Consent and Patient Details

A patient's right to privacy is paramount. Written consents for including patient details, images, or personal information must be retained by the authors and provided to the Journal upon request. Unless written permission has been obtained, all personal details must be removed before submission.

Registration of Research

In line with the Declaration of Helsinki 2013 (article 35), all research studies involving human participants must be registered in a publicly accessible database before recruitment of the first subject. Authors must provide their Unique Identifying Number (UIN) from the Research Registry or another registry at submission.

Reporting Guidelines

Compliance with the relevant reporting guideline is mandatory. Authors must submit a completed checklist indicating page numbers where compliance is achieved, and state in the Methods section that the research is reported in line with the named guideline.

Financial Support and Competing Interests

All authors must disclose financial and personal relationships that could bias their work. A financial disclosure questionnaire must be completed by the corresponding author at initial submission. All relevant conflicts of interest must also be clearly stated in the Acknowledgements section of the manuscript.

Permissions and Ownership

All submitted figures must be owned solely by the author(s). For figures not meeting this requirement, authors must obtain permission for use in JOP. The following materials require written permission from the copyright holder:

• Previously published figures, adapted tables, or direct quotations of more than 50 words;
• Unpublished data (personal communications, manuscripts in preparation);
• Photographs revealing unmasked faces.

Credit must be included in the figure legend for all figures reprinted with permission.

Product Information

Medications, materials, and devices must be identified by full non-proprietary name, along with brand name and manufacturer where appropriate. Place this information in parentheses in the text.

Retractions

JOP is a member of the Committee on Publication Ethics (COPE) and follows ICMJE advice on scientific misconduct, expressions of concern, retractions, and overlapping publications.

Article Types

Manuscript Preparation and Formatting

Manuscripts must be written in clear, grammatical English. Manuscripts not conforming to journal format will be returned for modification. Acceptable file types are .DOC and .DOCX; do not submit PDF.

• Text should be 1.5-spaced.
• Body text: 10–12 pt.
• Do not add line numbers (the system generates these automatically).
• Brevity is appreciated; avoid repeating the same information in the Abstract, Introduction, and Discussion.
• Title page, footnotes, abbreviations, and abstract pages must be included in the main body file.

Page 1 — Title Page

• Title. Concise, descriptive, and informative. Include the study design (e.g. "randomised controlled trial", "systematic review"). Avoid abbreviations and brand names.
• Authors. Full first name, middle initials, last name, and highest academic degrees. For large groups or consortia, list qualifying individuals plus the group name; all other names in Acknowledgements.
• Corresponding author. One author designated with a current email address and full mailing address.

Page 2 — Abstract

Original articles: structured abstract (max 300 words) with headings: Introduction; Methods; Results; Conclusions. Review articles: unstructured abstract (max 250 words).

Main Body Structure

• Introduction. Purpose of the work, the problem addressed, and a brief summary of relevant prior investigations.
• Methods. Sufficient detail to allow reproduction. Reference previously published methods; include ethical and statistical information.
• Results. Concise; avoid redundant tables or figures illustrating the same data.
• Discussion. Explore the significance of results; do not repeat them.
• Acknowledgements. Three separate paragraphs: (1) Assistance with the study; (2) Financial support and sponsorship; (3) Conflicts of interest. State "none" where applicable.
• Presentation (original articles). Acknowledge any preliminary presentation at international meetings, or state "Presentation: none."

References

References must follow the AMA Manual of Style. All references cited in the text must be listed and cited by number (footnotes not accepted). Use superscript Arabic numerals in consecutive order, outside periods and commas, inside colons and semicolons.

• List all authors for references with 6 or fewer; for more than 6, list the first 3 followed by "et al."
• Use full-page ranges (e.g. 426–429, not 426–9).
• Abbreviate and italicise journal names per PubMed / NLM style.
• "Submitted for publication" and "personal communication" may not appear in the reference list; cite parenthetically in text instead.
• Papers "in press" (accepted) should appear in the reference list.

Tables

Number tables consecutively and cite in order of appearance. Each table should be typed on a separate document, 1.5-spaced, with a brief heading, appropriate column heads, and legends. Do not embed tables in the manuscript file or submit as photographs. Abbreviations in tables must be defined in footnotes. Use data from other sources only with permission, citing the original source.

Figures and Figure Legends

Upload each figure as a separate file at the highest resolution available. Required resolutions:

• Line art (pure black and white): 1200 DPI
• Halftone images (B&W or colour): 300 DPI minimum
• Combination halftones: 600 DPI

Accepted formats for final accepted manuscripts: EPS, TIFF, MS Office (DOC, PPT, XLS). Do not embed figures in the main body file. Designate each figure as GRAYSCALE or RGB. All figure legends should appear at the end of the manuscript document following the reference list, numbered correctly. All symbols and abbreviations in figures must be defined in the legend.

If photographs of people are used, identities must be obscured unless written consent has been obtained. If a figure has been published before, the original source must be acknowledged and written permission submitted.

Supplemental Digital Content (SDC)

Authors may submit SDC (text, tables, figures, audio, video) to supplement the manuscript. SDC should be cited consecutively in the main text. SDC files are not copyedited and will be presented digitally as submitted.

• Format: PDF preferred; include article title and first author.
• Video: Accepted formats: .wmv, .mov, .flv, .qt, .mpg, .mpeg, .mp4. Max 10 minutes; minimum screen size 320×240 px; embedded English audio narration required.
• Total SDC size per submission: Max 10 MB.

Online Manuscript Submission

New Submissions

Once your manuscript is ready, submit it via the Editorial Manager portal at www.editorialmanager.com/ejop/default.aspx. A manuscript number will be assigned once the submission has been vetted for compliance. Faxed, scanned, or emailed manuscripts will not be accepted.

Mandatory Licence to Publish

Upon first revision, authors must complete a Licence to Publish (LTP) form, available from the submission site. The Corresponding Author may sign on behalf of all co-authors. Authors retain copyright for all articles and grant the journal a licence to publish the article. Manuscripts will not pass to production without completed LTP forms.

Article Processing Charges

JOP is an open access, peer-reviewed journal. Authors of accepted articles pay an Article Processing Charge (APC) to enable perpetual, unrestricted online access immediately upon publication.

The APC is charged on acceptance and must be paid within 30 days by credit card. Payment must be received in full before the article is published.

Creative Commons Licenses

Open access articles are freely available to read, download, and share from the time of publication. Authors choose one of the following Creative Commons 4.0 licences after acceptance:

NIH Public Access Policy: The Journal is compliant with the NIH Public Access Policy.

Page Proofs

Authors will receive email notification when PDF proofs of their article are available. Authors must carefully examine the proofs, correct any inaccuracies, and answer all queries within 48 hours. Only critical corrections to content accuracy will be made; stylistic changes, reworking of accepted material, rewriting of text, or adapting tables and figures are not permitted at this stage. Corrections or approval should be sent to the Production Editor by email or fax.